Investigates the role of fibrillin-1 in inhibiting adipogenic differentiation in mice, suggesting new pathways for obesity treatment.
mice, which show that global fibrillin-1 deficiency leads to sex-dependent obesity by negatively regulating early adipogenic stem cell differentiation. However, the underlying cell receptors and mechanisms remained unknown. Here, we used recombinant fibrillin-1 fragments harboring either an active RGD integrin-binding motif (rFBN1-N-RGD) or an inactive RGA motif (rFBN1-N-RGA) and tested their roles in adipogenic differentiation with primary mesenchymal progenitors isolated from bone marrow or fat tissue, as well as with adipogenic 3T3-L1 cells. rFBN1-N-RGD inhibited adipogenic differentiation in all cell models when present during the early commitment phase but not during the maturation phase, whereas the rFBN1-N-RGA control was inactive. siRNA-mediated gene silencing or pharmacologic inhibition of integrin αvβ3, but not α5β1, rescued rFBN1-N-RGD-dependent inhibition of adipogenic differentiation. Fibrillin-1 engagement of integrin αvβ3 triggered activation of the downstream focal adhesion kinase (Fak)-Src kinase (Src) signaling cascade, driving extracellular signal-regulated kinase (Erk) activation. This cascade suppressed early adipogenic transcriptional programs by restraining Cebpα and Pparγ activation, thereby maintaining progenitor cells in a committed but undifferentiated state. Pharmacological inhibition of Fak, Src and Erk restored the anti-adipogenic effect of rFBN1-N-RGD. These data establish the integrin αvβ3-Fak-Src-Erk axis as an important signaling pathway by which fibrillin-1 imposes an adipogenic checkpoint during the early adipogenic commitment phase, thereby limiting excessive differentiation.
No takes yet. Share an insight, caveat, or question.
Siddiqui et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: